These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2582862)

  • 1. Simple conversion from intravenous aminophylline to twice daily oral theophylline.
    Pleasants RA; Williams DM
    Chest; 1989 Dec; 96(6):1440. PubMed ID: 2582862
    [No Abstract]   [Full Text] [Related]  

  • 2. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe and effective use of sustained-release and intravenous theophylline.
    Boggs PB
    Compr Ther; 1982 Mar; 8(3):17-21. PubMed ID: 7067393
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose conversion from aminophylline to theophylline in preterm infants.
    Reese J; Prentice G; Yu VY
    Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F51-2. PubMed ID: 8092873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions.
    Steinijans VW; Schulz HU; Böhm A; Beier W
    Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential use of aminophylline and theophylline for the treatment of atropine-resistant bradycardia after spinal cord injury: a case report.
    Sakamoto T; Sadanaga T; Okazaki T
    J Cardiol; 2007 Feb; 49(2):91-6. PubMed ID: 17354583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative pharmacokinetics of theophylline and aminophylline in man.
    Aslaksen A; Bakke OM; Vigander T
    Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
    Steinijans VW; Zech K; Fischer R
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accidental coadministration of intravenous aminophylline and theophylline by mouth: a hazardous practice.
    Frewin DB; Cooper DJ
    Med J Aust; 1986 Apr; 144(9):481-2. PubMed ID: 3702795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of a delayed-action aminophylline preparation].
    Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
    Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S; Raina RK; Samotra K; Gupta KL
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous aminophylline in patients already taking oral theophylline: effect on calculated dose of knowledge of serum theophylline concentration on admission.
    Wiggins J; Arbab OA; Stableforth DE; Ayres JG
    Thorax; 1986 Oct; 41(10):759-65. PubMed ID: 3538477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.